Colonoscopy vs the Fecal Immunochemical Test: Which is Best?
Gastroenterology
; 166(5): 758-771, 2024 05.
Article
em En
| MEDLINE
| ID: mdl-38342196
ABSTRACT
Although there is no debate around the effectiveness of colorectal cancer screening in reducing disease burden, there remains a question regarding the most effective and cost-effective screening modality. Current United States guidelines present a panel of options that include the 2 most commonly used modalities, colonoscopy and stool testing with the fecal immunochemical test (FIT). Large-scale comparative effectiveness trials comparing colonoscopy and FIT for colorectal cancer outcomes are underway, but results are not yet available. This review will separately state the "best case" for FIT and colonoscopy as the screening tool of first choice. In addition, the review will examine these modalities from a health economics perspective to provide the reader further context about the relative advantages of these commonly used tests.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Colorretais
/
Colonoscopia
/
Análise Custo-Benefício
/
Detecção Precoce de Câncer
/
Sangue Oculto
Limite:
Humans
Idioma:
En
Revista:
Gastroenterology
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
Estados Unidos